Abstract
Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have